X4 Pharmaceuticals Non Operating Income Net Other Over Time
| XFOR Stock | USD 3.62 0.08 2.16% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out X4 Pharmaceuticals Performance and X4 Pharmaceuticals Correlation. Can Biotechnology industry sustain growth momentum? Does XFOR have expansion opportunities? Factors like these will boost the valuation of X4 Pharmaceuticals. Anticipated expansion of XFOR directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating X4 Pharmaceuticals demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (8.92) | Revenue Per Share | Quarterly Revenue Growth 2.152 | Return On Assets | Return On Equity |
Investors evaluate X4 Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating X4 Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause X4 Pharmaceuticals' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between X4 Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if X4 Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, X4 Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Non Operating Income Net Other Analysis
Compare X4 Pharmaceuticals and related stocks such as Aligos Therapeutics, Karyopharm Therapeutics, and FibroGen Non Operating Income Net Other Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALGS | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (109 K) | (57 K) | (57 K) | (57 K) | (65.5 K) | (68.8 K) |
| KPTI | 3 K | 3 K | 3 K | 3 K | 69 K | 895 K | 1.3 M | 1.6 M | 4 M | 5.4 M | 3 M | 497 K | 2.3 M | 2.3 M | 2.3 M | 2.6 M | 2.1 M |
| MRSN | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 2.2 M | 424 K | 65 K | 65 K | 65 K | 65 K | 58.5 K | 55.6 K |
| SNTI | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 9.6 M | 8.6 M |
| INMB | 77.7 K | 77.7 K | 77.7 K | 77.7 K | 77.7 K | 77.7 K | 77.7 K | 77.7 K | 77.7 K | 77.7 K | 128.5 K | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.1 M) | (1 M) |
X4 Pharmaceuticals and related stocks such as Aligos Therapeutics, Karyopharm Therapeutics, and FibroGen Non Operating Income Net Other description
My Equities
My Current Equities and Potential Positions
| X4 Pharmaceuticals | XFOR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 61 North Beacon |
| Exchange | NASDAQ Exchange |
USD 3.62
Additional Tools for XFOR Stock Analysis
When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.